Latino/Hispanic
Showing 9976 - 10000 of >10,000
Lupus Trial in Worldwide (BMS-931699, Placebo matching BMS-931699)
B-Cell Lymphoma Originating in the CNS Trial in Los Angeles (Temozolomide)
Terminated
- B-Cell Lymphoma Originating in the CNS
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Oct 23, 2018
Leukemia, Acute, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS) Trial in Stanford (Regulatory T-cells,
Terminated
- Leukemia, Acute
- +6 more
- Regulatory T-cells
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 1, 2018
Rheumatoid Arthritis Trial in United States (Andecaliximab, Placebo, Methotrexate)
Osteosarcoma, Sarcoma Trial in Saint Louis (Microwave ablation, Cryoablation, Radiofrequency ablation)
Terminated
- Osteosarcoma
- Sarcoma
- Microwave ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 23, 2018
Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),
Completed
- Acute Leukemia
- +8 more
- Tacrolimus (ARM with Methotrexate)
- +7 more
-
Duarte, California
- +29 more
Jan 2, 2019
Hepatoma, Liver Tumors, Adenoma, Liver Cell Trial run by the NCI (TRC 105, Sorafenib)
Completed
- Hepatoma
- +4 more
- TRC 105
- Sorafenib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 2, 2019
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (Azacitidine, Docetaxel,
Terminated
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Azacitidine
- +6 more
-
Los Angeles, California
- +4 more
Jun 29, 2018
Squamous Cell Carcinoma of the Skin, Recurrent Skin Cancer Trial in Stanford (Capecitabine)
Terminated
- Squamous Cell Carcinoma of the Skin
- Recurrent Skin Cancer
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 15, 2018
Multiple Myeloma Trial in Richmond (Azacitidine)
Completed
- Multiple Myeloma
-
Richmond, VirginiaVirginia Commonwealth University
May 31, 2018
Metastatic Colorectal Cancer Trial in Worldwide (Sym004 (12 mg/kg), Sym004 (9/6 mg/kg), Best Supportive Care (BSC))
Completed
- Metastatic Colorectal Cancer
- Sym004 (12 mg/kg)
- +4 more
-
Los Angeles, California
- +53 more
Apr 9, 2019
Leukemia, Lymphoid Malignancies, Metastatic Malignant Tumor to the Leptomeninges Trial in Houston (Intrathecal Rituximab)
Terminated
- Leukemia
- +2 more
- Intrathecal Rituximab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 26, 2018
Sleep Disordered Breathing, Nocturnal Oxygen Desaturation, Upper Airway Edema Trial in Boston (procedure, device, other)
Completed
- Sleep Disordered Breathing
- +2 more
- Forty-five degrees elevated upper body position
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Jun 8, 2018
Temporomandibular Joint Dysfunction Syndrome Trial in Saint Paul (PACT Experimental Arm)
Completed
- Temporomandibular Joint Dysfunction Syndrome
- PACT Experimental Arm
-
Saint Paul, MinnesotaHealthPartners Clinic
May 16, 2018
Dentin Sensitivity Trial in Bristol (Stannous fluoride, Sodium monofluorophosphate, Mineral water)
Completed
- Dentin Sensitivity
- Stannous fluoride
- +2 more
-
Bristol, United KingdomGSK Investigational Site
Mar 19, 2018
Female Orgasmic Disorder Trial in Australia, Canada, United States (Placebo, Low dose TBS-2, Medium dose TBS-2)
Completed
- Female Orgasmic Disorder
- Placebo
- +3 more
-
Birmingham, Alabama
- +52 more
Aug 9, 2018
Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)
Completed
- Cholangiocarcinoma
- Nab-Paclitaxel and Gemcitabine
-
Denver, Colorado
- +24 more
Sep 5, 2018
Cystinosis Trial in France, Netherlands, United States (Cysteamine Bitartrate Delayed-release Capsules)
Completed
- Cystinosis
- Cysteamine Bitartrate Delayed-release Capsules
-
San Francisco, California
- +9 more
Jun 26, 2018
Skin Aging Trial in Broomall (Active Mask, Sham Mask)
Completed
- Skin Aging
- Active Mask
- Sham Mask
-
Broomall, PennsylvaniaKGL Skin Study Center, LLC
Mar 4, 2019
Idiopathic Pulmonary Fibrosis Trial in Worldwide (Nintedanib, Pirfenidone)
Completed
- Idiopathic Pulmonary Fibrosis
-
Los Angeles, California
- +37 more
May 16, 2018